CAS: 10030-90-7; Iron(Ii) Succinate
该化合物是含有分子分子式C4H4FeO4的铁(II)化合物, 这个协调综合体因其稳定性和水溶性而显著可见, 适合医药, 农业和工业催化的应用. 铁(II) 中心由杂酚固的离心机进行镀, 提高了营养补充剂的生物利用率. 它受控制的释放特性, 以及与其他铁盐相比胃肠刺激的减少, 使得它更有利于铁质强化. 此外, 它作为合成化学的先质和有机反应的催化剂. 化合物的精确结构确保了专门配方的一贯性能.
- 英文名称Iron(Ii) Succinate
- 中文名称丁二酸亚铁
- IUPAC名称iron(II) succinate
- 其它别名Eisen(Ii)-Succinat; Iron(Ii)-Succinate; Ferroussuccinate,18.5%,Powder; Succinic Acid Iron(Ii) Salt; Ferrous Succinic Acid; Ferrous Succinate (Iron Succinate); Iron Succinate Usp/ep/bp; Butanedioate,Iron(2+)
- CAS编号10030-90-7
- MFCD编号:MFCD00672154
- EINECS号:233-082-3
- FDA UNII编号:818ZYK7N91
- 分子式:C4H4FeO4分子量:171.92
- 产品CID: 7898
- 产品分类原料药 → 血液系统用药 → 抗贫血药
物理性质
MSDS等安全信息
合成工艺路线路线简述
海关参考信息
- 2905399002-1,4-丁二醇
- 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:EP-1363951-B1
优先权日:2000-12-07
标 题 :Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
发明人：ILIC LJUBOMIR; RISTIC SUZANA; CAKIC MILORAD; NIKOLIC GORAN; STANKOVIC SLOBODAN
权利人:AD ZDRAVLJE FARMACEUTSKO HEMIJ
摘要:A polynuclear complex of pullulan oligomers of formula (I): wherein n = (100-8200), obtained by process of synthesis of soluble pullulan with insoluble iron (III)-hydroxyde of formula (II): wherein n=(900). The process of synthesis is characterized by technical simplicity and economy. In accordance with suggested process, first of all, preparation of pullulan for synthesis, including its characterization (determination of RG, Mw, Mn, [θ]) is carried out, and subsequently its hydrogenation is carried out in order to eliminate reducing groups, iron(III)-hydroxyde gel is prepared, and synthesis of the complex can start. Obtained complex is afterwards prepared for pharmacological use and it is subjected to the subsequent physical and chemical processes of purification. The preparation obtained in such a way is used for prevention and treatment of syderopenic anemia in human and veterinay medicine.
专利号:US-2024285670-A1
优先权日:2021-06-11
标题 :Therapeutic treatment of tumors by blocking the heme synthesis-export axis
发明人：TOLOSANO EMANUELA; FIORITO VERONICA; PETRILLO SARA; CHIABRANDO DEBORAH; ALLOCCO ANNA LUCIA; BERTINO FRANCESCA
权利人:UNIV DEGLI STUDI DI TORINO
摘要:A blocker of heme synthesis-export axis as active agent for use in the treatment of a tumor in a subject, wherein the blocker of heme synthesis-export axis upmodulates oxidative metabolism of tumor cells by upregulating the tricarboxylic acid (TCA) cycle and the oxidative phosphorylation (OXPHOS).
专利号:CN-117361562-A
优先权日:2023-10-24
标 题 :Crystallization synthesis of a high-content framework iron ZSM-35 molecular sieve
专利号:WO-2022259144-A1
优先权日:2021-06-11
标 题:Therapeutic treatment of tumors by blocking the heme synthesis-export axis
专利号:EP-4351555-A1
优先权日:2021-06-11
标 题:Therapeutic treatment of tumors by blocking the heme synthesis-export axis
专利号:IT-202100015368-A1
优先权日:2021-06-11
标 题:THERAPEUTIC TREATMENT OF CANCER THROUGH BLOCK OF THE HEME SYNTHESIS-EXPORT AXIS
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:Compound: Butanedioic acid, iron salt (1: )
📝 需求与反馈
尽可能描述清楚需求与问题信息
